A Study to Evaluate ALN-2232 in Participants With Obesity

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Trial Site, Mount Royal, Canada

Study leads

Medical Director
Study Director
Alnylam Pharmaceuticals

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Overweight and/or Obesity · Weight Management

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity · Knee Osteoarthritis (OA)

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Walnut Creek, United States

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

Obesity

Abroad (travel likely)RecruitingPHASE3

Anniston, United States · Walnut Creek, United States

Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

Obesity & Overweight · Hyperlipidemia

Abroad (travel likely)Recruiting

Shanghai, China